|
Thomas Tobin
Toxicologist, Pharmacologist, Veterinarian
|
Address
Rm. 128C Maxwell H. Gluck Equine Research Center
Department of Veterinary Science, University of Kentucky
Lexington, KY USA 40546-0099
Office: 859-218-1092 FAX: 859- 257-8542
Dept Vet Science: 859-257-4757
Univ of Kentucky e-mail: ttobin(att)uky.edu
Personal e-mail: thomastobin(att)me.com
phone 859-229-9392
Replace (att) with @
Education
MVB (DVM) University College, Dublin, 1964
MSc,
Pharmacology, U of Guelph 1966
PhD, Pharmacology, University of Toronto, 1970
MRCVS
– Member, Royal College of Veterinary Surgeons, 1964-date
Licenses / Boards
Kentucky
Veterinary License, NS-1053. Ontario Vet. license, 1964-1978
DABT, Diplomate, American Board of Toxicology,
1980-2015
Employment
Professor of Veterinary Science, Gluck Equine Research Center, University
of Kentucky
Professor, Graduate Center for Toxicology, University of Kentucky,
1975-date
|
Intellectual
Property, Patents
1) 1984: US Patent #
4,473,640 for morphine detection:“Detection of Morphine and its analogues
using enzymatic hydrolysis”
2) 1999: US Patent # 5,883,095
for treatment of EPM (1999) “Formulations and methods to treat and prevent
Equine Protozoal Myeloencephalitis”
3) 2006: US Patent # 7,074,834
for an equine tranquilizer (2006); “Long acting, reversible veterinary
sedative and analgesic and method of use.”
Licensed IPs, Companies
1) 1987-1989International
Diagnostic Systems,; Royalty arrangements for fentanyl, carfentanil,
furosemide, acepromazine, cocaine, detomidine, phenylbutazone, alfentanil,
sufentanil and 20-plus others, in ELISA and PCFIA format,
2) 1991: WTT, Inc., created by
UK
with licenses for 50- plus ELISA tests, 1991. Sold to Neogen, Inc., ELISA
Technologies, 1993.
3) 1999: US Patent # 5,583,095 licensed to Bayer, first FDA approved
treatment for Equine Protozoal Myeloencephalitis, marketed as Marquis®,
August 2001,
4) 1999:
20 metabolites/regulatory analytes/deuterated standards licensed to Neogen.
5) 2011: 12 other
metabolites/regulatory analytes/deuterated standards certified reference
standards, licensed to Frontier BioPharm, March 2011.
Copyrights, Royalities
2003: Unusual mathematical analysis
and biologically unique pathogenesis of MRLS copyrighted (
US
Copyright# TXU1111484). Other copyrights and IP
royalties.
Teaching
Toxicology, Pharmacology, “Ethics in Scientific Research,”
“Risk Assessment,” International Short Courses:
“The Commission Veterinarian/Equine Medical Director” 1995 to
2001, and “Testing for Therapeutic Medications, Dietary and Environmental
Substances.” Six Kentucky Veterinarian’s Short Courses, 2000-2001.
Bain-Fallon Lectures, Australia, 1990 and 2002.
Workshop on Mare Reproductive Loss Syndrome (MRLS), August 2002,
Published, May 2003.
Honors
Ontario Government Faculty Training Grant 1966 Massey College Junior
Fellow, Toronto, Ontario 1967-70, HBPA Man of the Year, 1995; Kentucky HBPA
Man of the Year, 1999; Toxicology Student Award, 1993; Toxicology rated the
only “extremely effective” graduate program in Kentucky by National
Research Council, 1992-93; Bain Fallon Lectures, 1989; The “Dr. Thomas
Tobin Purse,” August 1, Emerald Downs, Seattle,
Washington, 1999; Millennium Medal, Dubai, 2001. Honorary faculty, College
of Veterinary Medicine, Cordoba, Argentina, “Thomas Tobin Purse”,
Cordoba, August, 2001. The
Professor Thomas Tobin Trophy,
Cayamanas Racetrack
,
Jamaica
,
April 20th, 2002
. Bain-Fallon
Lectures,
Gold Coast
,
Australia
, July 2002, Thomas Tobin Purse,
Sao Paulo
,
Brazil
, 2007, National HBPA 2008 Industrial Service
Award, 2009.
Research Support
Approximately $15 million
through 2012.
Publications:
Books, Workshops, Symposia
About 400 plus papers, 100-plus abstracts, two books, five volumes of
proceedings. Numerous articles published and reprinted in lay journals.
1) Drugs and the Performance Horse, by
Thomas Tobin. Foreword by HRH, The Duke of
Edinburgh
. 480 pp.,
Springfield
,
Illinois
: Charles C. Thomas, 1981.
2) Proceedings of the Workshop on
Testing for Therapeutic Medications, Environmental and Dietary Substances in
Racing Horse. 218 pages, 1995.
3) Proceedings of the First Workshop
on the Mare Reproductive Loss Syndrome. 134 pages, 2002.
4) Equine Drug Testing and Therapeutic
Medication Regulation: 2009 Policy
of The National HBPA,
160 pages, Wind
Publications, 2009, Nicholasville, KY
5) World Rules for Equine Drug Testing and Therapeutic
Medication Regulation: 2012
Policy of The
National HBPA,
280 pages, Wind Publications, 2012, Nicholasville, KY

|